Xcelerate Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XCRT research report →
About the company
Xcelerate Inc. specializes in sourcing and integrating engineering expertise and patents, which it then applies to nascent medical technology ventures. The firm's offerings are subsequently deployed within regulated clinical settings for rigorous evaluation, validation, and real-world implementation.
- CEO
- Michael F. O'Shea
- IPO
- 2001
- Employees
- 12
- HQ
- Coral Springs, FL, US
Price Chart
- Market Cap
- $4.74M
- P/E
- -4.19
- P/S
- -7.32
- P/B
- -2.29
- EV/EBITDA
- -53.99
- Div Yield
- 0.00%
- Gross Margin
- 51.22%
- Op Margin
- 24.49%
- Net Margin
- 174.19%
- ROE
- 70.39%
- ROIC
- 74.50%
- Revenue
- $0 · -100.00%
- Net Income
- $-1,218,458 · -76.91%
- EPS
- $-0.00 · -75.00%
- Op Income
- $-258,816
- FCF YoY
- 51.52%
- 52W High
- $0.02
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 1.75
- Avg Volume
- 138.29K
Get TickerSpark's AI analysis on XCRT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our XCRT coverage
Recent articles, reports, and earnings notes.
No research on XCRT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate XCRT report →Similar companies
Peers in the same neighborhood.